Clinical Trial Update: S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone [Phase 2]

View source ↗

Summary

Phase 2 trial S0344 evaluating intralesional resection for chondrosarcoma of the bone has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma of Bone

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Sarcoma | Phase 2 | Status: COMPLETED